Related Experiment Videos
Mitolactol chemotherapy for malignant melanoma: a phase II study
Cancer Treatment Reports
|July 1, 1984
Abstract:
Fifty-one patients (43 evaluable) with malignant melanoma were treated with mitolactol in an intermittent oral schedule. There were four objective tumor responses, all occurring in patients previously treated with dacarbazine.